LM N°2/ 2024. STATE OF RESEARCH IN 2024. ALTERATIONS IN MUCOSAL TRANSUDATION IN VULVOVAGINAL ATROPHY: WHAT MECHANISMS ARE INVOLVED? THE ROLE OF HYALURONIC ACID IN INFLUENCING VAGINAL LUBRICATION. Denis COUCHOUREL, PhD Scientific and Medical Director, Laboratoires VIVACY 

taboo lm3

The state of the art in 2024 on HA research ALTERATIONS OF MUQUEOUS TRANSSUDATION IN VULVO- VAGINAL ATROPHIES: WHAT MECHANISMS ARE INVOLVED? THE ROLE OF HYALURONIC ACID IN INFLUENCING VAGINAL LUBRICATION. Denis COUCHOUREL, PhD Scientific and Medical Director, VIVACY Laboratories INTRODUCTION In 2014, the [...]

LM N°2/ 2023. Theme 1: Genitourinary health after breast cancer. Hyaluronic acid: from endogenous molecules to injectable gels. Denis Couchourel, Phd, Vivacy Laboratory

hyaluronic acid

Hyaluronic acid: from the endogenous molecule to injectable gels Denis COUCHOUREL, PhD Scientific and Medical Director, Laboratoires VIVACY Hyaluronic acid is an endogenous molecule essential to extracellular matrices, with remarkable properties that are exploited by the body in very specific compartments (vitreous humor, joint cavity...). It is also a biologically active molecule involved in the [...]

LM N°1 / 2023. Alterations in mucosal transudation in vulvovaginal atrophy: mechanisms involved? The role of hyaluronic acid. Denis COUCHOUREL, PhD, Medical and Scientific Director, Vivacy Laboratories

Denis Couchourel, PhD

Still taboo subjects. Alterations in mucosal transudation in vulvovaginal atrophy: what mechanisms are involved? Influence of hyaluronic acid. Denis COUCHOUREL, PhD, Medical and Scientific Director, Vivacy Laboratories Introduction In 2014, the foundations for the definition of genitourinary menopausal syndrome were laid (Portman et al, 2014). In [...]

en_US

Aesthetic health based on scientific evidence

Sign up to view this latest issue on vivacy and receive future issues of LM.